This lack of predictability in the timing of DEA's scheduling decisions leads to unnecessary uncertainty in the drug development process.

H.R. 4299, the Improving Regulatory Transparency for New Medical Therapies Act, which Ranking Member Pallone and I introduced.

H.R. 4299, which seeks to improve the transparency and consistency of DEA's scheduling of new FDA-approved drugs.

This has been a very important hearing, very compelling testimony, very informative.

the continued hiding behind HIPAA has got to stop.

I would like to commend my colleague from Pennsylvania, Dr. Murphy, for his yearlong investigation into mental health issues.

I am pleased with Dr. Murphy's bill. It includes a provision to extend the liability for doctors who volunteer in behavioral health clinics.

Congress is aware of your plight and we can do better.

For far too long, those who need help have been getting it the least, and where there is no help, there is no hope.

Millions of Americans suffer with severe mental illnesses, such as bipolar disorder, schizophrenia, and major depression.

I am glad that, today, we will pass a bill that will help keep American children healthy. Today, the House considers S. 1557, the Children's Hospital GME Support Reauthorization Act of 2013. This is companion legislation to my own bill…

I am very pleased to ask all Members to support S. 1557, very important legislation with bipartisan support, and I yield back the balance of my time.